AXGN.NASDAQAxogen, INC

4/A: Axogen Executive Jens Kemp Reports Share Transactions and Correction to Previous Filing

Sentiment:

SEC Form 4/A


Jens Kemp, Chief Marketing Officer of Axogen, Inc., reports the acquisition and disposal of company shares, along with a correction to a previously filed Form 4 regarding restricted stock units.

Summary

  • On February 22, 2025, Jens Kemp acquired 2,500 shares of Axogen common stock upon the attainment of certain performance criteria.
  • On February 25, 2025, Kemp disposed of 814 shares to cover tax withholding obligations related to the vesting of performance stock units (PSUs).
  • The shares were sold at a weighted average price of $16.49, with individual transactions ranging from $16.42 to $17.32 per share.
  • Following these transactions, Kemp beneficially owns 31,686 shares of Axogen common stock.
  • An amendment to the original Form 4 filed on February 26, 2025, was made to include 30,000 shares of common stock representing 30,000 restricted stock units in the beneficial number of shares of common stock outstanding.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions and a correction, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is a common occurrence in publicly traded companies. It provides transparency to investors regarding insider activity.

Stakeholder Impact

  • The disclosure of share transactions provides transparency to shareholders regarding insider activity.

Key Dates

DateDescription
02/22/2025Acquisition of 2,500 shares of common stock upon attainment of performance criteria.
02/24/2025Deemed execution date for the acquisition of shares.
02/25/2025Disposal of 814 shares to cover tax withholding obligations.
02/26/2025Date of original Form 4 filing and date of amendment.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.